Muscle pain and muscle weakness in COVID19 patients: Cross-talk with statins – Preliminary results
Authors:
Open Access
- 24 February 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 148, 112757
Abstract
No abstract availableKeywords
Funding Information
- Gdański Uniwersytet Medyczny (ST-22)
This publication has 38 references indexed in Scilit:
- Discontinuation of statin therapy due to muscular side effects: A survey in real lifeNutrition, Metabolism and Cardiovascular Diseases, 2013
- Managing the underestimated risk of statin-associated myopathyInternational Journal of Cardiology, 2012
- Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Exertional Rhabdomyolysis and Acute Kidney InjuryThe Physician and Sportsmedicine, 2009
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- Bacterial, Fungal, Parasitic, and Viral MyositisClinical Microbiology Reviews, 2008
- Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO StudyCardiovascular Drugs and Therapy, 2005
- NK-104: a novel synthetic HMG-CoA reductase inhibitorExpert Opinion on Investigational Drugs, 2000
- PravastatinDrugs, 1991
- Increased serum creatine kinase after exerciseNeurology, 1979